Portugal – Antineoplastic and immunomodulating agents – 2023/0671 - CERTOLIZUMAB PEGOL [200 MG/ 1 ML; CANETA]
Tender Description
CERTOLIZUMAB PEGOL [200 MG/ 1 ML; CANETA]
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.
